Table 1.
Author | CASP Questions (Q) | Judgement | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Section A 1 | Section B 2 | Section C 3 | Score 4 | |||||||||||
Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | ∑ yes | ∑ no | ∑ can’t tell | |
Bakker et al. [24] | + | + | + | + | + | + | + | + | + | + | + | 11 | ||
Bendix et al. [32] | + | + | + | − | + | + | + | + | + | + | − | 9 | 2 | |
Bergström et al. [27] | + | + | + | + | + | + | + | + | + | + − | + | 10 | 1 | |
Christensen et al. [31] | + | + − | + | + − | + − | + | + | + − | + | + | + − | 6 | 5 | |
Daalgard et al. [29] | + | + | + | + − | + | + | + | + | + | + | + | 10 | 1 | |
De Buck et al. [19] | + | + | + | + | + | + | + | + | + | + | + | 11 | ||
Detaille et al. [1] | + | + | + | + | + | + | + | + | + | + − | + − | 9 | 2 | |
Friedrich et al. [20] | + | + | + | + | + | + | + | + | + | + | + | 11 | ||
Lambeek et al. [28] | + | + | + | − | + | + | + | + | + | + | + | 10 | 1 | |
Linton et al. [21] | + | + | + | + | + | + | + | + | + | + | + | 11 | ||
McGonagle et al. [26] | + | + | − | + − | + | + | + | + | + | + | + | 9 | 1 | 1 |
Nieuwenhuijsen et al. [22] | + | + | + | + | + | + | + | + | + | + | + | 11 | ||
Ntsiea et al. [23] | + | + | + | + | + | + | + | + | + | + | + | 11 | ||
Varekamp et al. [25] | + | + | + | − | + − | + | + | + | + | + | + − | 8 | 1 | 2 |
Kin Wong et al. [30] | + | + | + | − | + | + | + | + | + − | + | + − | 8 | 1 | 2 |
Legend: “+”―yes: “- “―no; “+ -“―can’t tell. 1 Are the results of the study valid? 2 What are the results? 3 Will the results help locally? 4 Methodological quality “yes” scores: 6–8 (good), 9–11 (very good); CASP Questions legend: Q1 = “Did the trial address a clearly focused issue?”; Q2 = “Was the assignment of patients to treatments randomized?”; Q3 = “Were all of the patients who entered the trial properly accounted for at its conclusion?”; Q4 = “Were patients, health workers and study personnel ‘blind’ to treatment?”; Q5 = “Were the groups similar at the start of the trial?”; Q6 = “Aside from the experimental intervention, were the groups treated equally?”; Q7 = “How large was the treatment effect?”; Q8 = “How precise was the estimate of the treatment effect?”; Q9 = “Can he results be applied to the local population, or in your context? ”; Q10 = “Were all clinically important outcomes considered?”; Q11 = “Are the benefits worth the harms and costs?